KER-050, AN INHIBITOR OF TGF-Β SUPERFAMILY SIGNALING, OBSERVED TO HAVE A RAPID, DYNAMIC, AND DURABLE EFFECT ON ERYTHROPOIESIS.

EHA Library, Marina Feigenson, 325516

CROSSTALK BETWEEN NITRIC OXIDE AND GLUCOCORTICOID RECEPTOR IS DISPENSABLE FOR INITIAL STRESS-INDUCED ERYTHROID PROGENITOR CELL EXPANSION

EHA Library, Sanja Momčilović, 325517

STUDY OF THE MACROPHAGE POLARISATION CONTINUUM WITH RELEVANCE TO COVID19

EHA Library, Charlotte Severn, 325518

NICHE HEALTH MAINTAINS SURVIVAL

EHA Library, Christina Schreck, 325519

IMMUNE STATUS IN HEMATOLOGICAL CANCER PATIENTS AFTER COVID19

EHA Library, Inna Kamaeva, 325520

RING CHROMOSOMES IN HEMATOLOGICAL MALIGNANCIES

EHA Library, Kalliopi Manola, 325521

CLINICAL OUTCOMES OF RELAPSED HODGKIN LYMPHOMA PATIENTS AFTER CONTEMPORARY FIRST-LINE TREATMENT: RESULTS FROM THE GERMAN HODGKIN STUDY GROUP

EHA Library, Paul J. Bröckelmann, 325522

MODIFICATION OF ESCALATED BEACOPP WITH DACARBAZINE SUBSTITUTION REDUCES TOXICITY WHILE MAINTAINING EFFICACY FOR THE TREATMENT OF ADVANCED-STAGE HODGKIN LYMPHOMA.

EHA Library, Anna Santarsieri, 325523

LONG-TERM FOLLOW-UP AND BIOMARKER ANALYSES OF RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED WITH BRENTUXIMAB VEDOTIN AND DHAP: THE HOVON/LLPC TRANSPLANT BRAVE STUDY

EHA Library, Julia Driessen, 325524

IMPACT OF THE FIRST COVID-19 LOCKDOWN IN GERMANY ON THE RATE OF ACUTE INFECTIONS DURING INTENSIVE CHEMOTHERAPY FOR HODGKIN LYMPHOMA

EHA Library, Anne Sophie Jacob, 325525

THYMUS AND ACTIVATION-REGULATE CHEMOKINE (TARC) IS A RELIABLE TUMOR MARKER FOR BOTH DIAGNOSIS AND MONITORING CLASSICAL HODGKIN LYMPHOMA

EHA Library, Szandra Boldizsar, 325526

BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN ADOLESCENTS AND YOUNG ADULTS (AYAS) WITH STAGE III OR IV HODGKIN LYMPHOMA: A SUBGROUP ANALYSIS FROM THE PHASE 3 ECHELON-1 STUDY

EHA Library, Andrew P. Grigg, 325527

BRENTUXIMAB VEDOTIN- CONTAINING REGIMENS FOR THE TREATMENT OF RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN CLINICAL PRACTICE: FOCUS ON SUBSEQUENT THERAPIES.

EHA Library, Evgeniya Borzenkova, 325528

OUTCOMES OF PATIENTS WITH INDETERMINATE RESPONSE DURING PD-1 INHIBITOR THERAPY FOR RELAPSED AND REFRACTORY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Liudmila Fedorova, 325529

PRELIMINARY RESULTS OF THE COMBINATION OF NIVOLUMAB AND DHAP IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (NIVO-DHAP) AS A SECOND-LINE THERAPY BEFORE AUTOLOGOUS HSCT

EHA Library, Nikita Mochkin, 325530

SUBCLINICAL COAGULATION DISORDERS IN NEWLY DIAGNOSED PATIENTS WITH HODGKIN LYMPHOMA (HL): A PHENOMENON RELATED TO THROMBOINFLAMMATION

EHA Library, Theodoros Vassilakopoulos, 325531

OUTCOME AND PROGNOSTIC FACTORS IN PATIENTS WITH ADVANCED HODGKIN LYMPHOMA WHO REMAIN PET/CT-POSITIVE AFTER 2 CYCLES OF ABVD: REAL-LIFE EXPERIENCE IN A MULTICENTER SETTING IN GREECE.

EHA Library, Theodoros Vassilakopoulos, 325532

TREATMENT OF HODGKIN DISEASE IN RELAPSE AFTER 3 LINES INCLUDING BRENTUXIMAB WITH DOSE DENSE PROTOCOL PLUS LENALIDOMIDE

EHA Library, Maher Salamoon, 325533

PET-STATUS AND PATIENTS WITH NEWLY HODGKIN LYMPHOMA (HL) PROGNOSIS: IS IT ALL THAT DEFINITIVE?

EHA Library, Olga Novosad, 325534

EVALUATION OF GONADAL FUNCTION IN YOUNG MEN AND WOMEN DIAGNOSED WITH HODGKIN LYMPHOMA

EHA Library, Angeliki Georgopoulou, 325535

ENDOCRINE DISORDERS IN HODGKIN LYMPHOMA SURVIVORS

EHA Library, Mariia Voytko, 325536

GERMAN EVIDENCE-BASED LIVING GUIDELINE ON DIAGNOSIS, THERAPY AND FOLLOW-UP OF ADULT PATIENTS WITH HODGKIN LYMPHOMA

EHA Library, Angela Aldin, 325537

TREATMENT OUTCOMES OF HODGKIN LYMPHOMA: PET GUIDED DE-ESCALATION IN REAL WORLD

EHA Library, Susmita Dasgupta, 325538

THE PROGNOSTIC VALUE OF PD-L1 AND PD-L2 LOCI ALTERATIONS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA TREATED WITH NIVOLUMAB

EHA Library, Lepik Kirill, 325539

IBRUTINIB PLUS RITUXIMAB (IR) VS PLACEBO PLUS RITUXIMAB (R) FOR WALDENSTROM’S MACROGLOBULINEMIA (WM): FINAL ANALYSIS AFTER FIVE YEARS OF FOLLOW-UP FROM THE RANDOMIZED PHASE 3 INNOVATE STUDY

EHA Library, Ramon Garcia-Sanz, 325540

PHASE 2 STUDY OF ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MAGNOLIA STUDY)

EHA Library, Stephen S. Opat, 325541

PRELIMINARY CLINICAL DATA FROM A PHASE 1B STUDY OF MAVORIXAFOR AND IBRUTINIB IN PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINEMIA WITH MYD88 AND CXCR4 MUTATIONS

EHA Library, Steven Treon, 325542

ROLE OF MAINTENANCE RITUXIMAB (MR) AFTER FIRST-LINE (1L) BENDAMUSTINE + RITUXIMAB (BR) OR R-CHOP IN PATIENTS (PTS) WITH MANTLE CELL LYMPHOMA (MCL) FROM A LARGE US REAL-WORLD (RW) COHORT

EHA Library, Gilles Salles, 325543

KTE-X19 VERSUS STANDARD OF CARE FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA PREVIOUSLY TREATED WITH BRUTON TYROSINE KINASE INHIBITORS: REAL-WORLD EVIDENCE FROM EUROPE

EHA Library, Georg Heß, 325544

OUTCOMES WITH KTE-X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ZUMA-2 WHO HAD PROGRESSION OF DISEASE WITHIN 24 MONTHS OF DIAGNOSIS

EHA Library, Michael L. Wang, 325545

EARLY SAFETY AND EFFICACY FINDINGS OF AUTO1 (CAT19), A FAST-OFF RATE CD19 CAR, IN RELAPSED /REFRACTORY INDOLENT B CELL LYMPHOMAS

EHA Library, Claire Roddie, 325546

ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL): LONG-TERM EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY

EHA Library, Yuqin Song, 325547

HIGH-RISK MANTLE CELL LYMPHOMA IN THE LYMA TRIAL: A LYSA STUDY.

EHA Library, Morgane Cheminant, 325548

UPDATED OUTCOMES WITH AXICABTAGENE CILOLEUCEL (AXI-CEL) RETREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA IN ZUMA-5

EHA Library, Julio Chavez, 325549

A PHASE ⅡSTUDY OF A SELECTIVE PI3KΔ INHIBITOR YY-20394 IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA.

EHA Library, lugui qiu, 325550

PREVALENCE OF SECOND CANCER DURING LONG TERM FOLLOW-UP IN HAIRY CELL LEUKEMIA PATIENTS TREATED WITH CLADRIBINE: A THIRTY-YEAR EXPERIENCE

EHA Library, Marianna Criscuolo, 325551

RISK FACTORS FOR POD24 IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Tingting Zhang, 325552

RITUXIMAB, BENDAMUSTINE, AND CYTARABINE (R-BAC) COMPARED WITH RITUXIMAB AND BENDAMUSTINE (BR) IN PREVIOUSLY UNTREATED ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA (BE-VE-BAC STUDY)

EHA Library, Giulia Bega, 325553

PRIMARY THERAPY AND RELATIVE SURVIVAL IN PATIENTS WITH LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM’S MACROGLOBULINEMIA (LPL/WM): A POPULATION-BASED STUDY IN THE NETHERLANDS, 1989-2018

EHA Library, Karima Amaador, 325554

TREATMENT PATTERNS AND OUTCOMES OF ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA UNFIT FOR STANDARD IMMUNOCHEMOTHERAPY: A UK AND IRELAND ANALYSIS

EHA Library, Alexandros Rampotas, 325555

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES OF 3455 PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA PATIENTS IN US ROUTINE CLINICAL PRACTICE

EHA Library, Peter Martin, 325556

COMBINATION OF EZH2 GENE MUTATION AND BCL2 GENE REARRANGEMENT AS AN INDICATOR OF FAVORABLE PROGNOSIS OF FOLLICULAR LYMPHOMA

EHA Library, Ekaterina Nesterova, 325557

LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH RITUXIMAB-RESISTANT INDOLENT B-CELL AND MANTLE CELL LYMPHOMAS: 10-YEAR FOLLOW-UP

EHA Library, Aditi Gupta, 325558

EFFECTS OF CONVENTIONAL TREATMENTS ON EARLY-STAGE PRIMARY CUTANEOUS MARGINAL ZONE LYMPHOMA

EHA Library, Lei Fan, 325559

EARLY INTERIM PET/CT PREDICTS THE OUTCOME IN HIGH-TUMOUR-BURDEN FOLLICULAR LYMPHOMA PATIENTS

EHA Library, Vít Procházka, 325560

RISK OF SECOND PRIMARY MALIGNANCIES IN PATIENTS WITH FOLLICULAR LYMPHOMA: A POPULATION-BASED STUDY IN THE NETHERLANDS

EHA Library, Manette Dinnessen, 325561

CONDITIONAL RELATIVE SURVIVAL IN LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM’S MACROGLOBULINEMIA (LPL/WM): A POPULATION-BASED STUDY IN THE NETHERLANDS

EHA Library, Karima Amaador, 325562

EFFICACY AND SAFETY OF ZANUBRUTINIB VERSUS RITUXIMAB-BASED CHEMOIMMUNOTHERAPY IN WALDENSTRÖM MACROGLOBULINEMIA: MATCHING-ADJUSTED INDIRECT COMPARISONS

EHA Library, Jorge Castillo, 325563

P53 IMMUNOHISTOCHEMISTRY DETECTS NON-PATHOGENIC MUTATIONS IN MANTLE CELL LYMPHOMA NECESSITATING TP53 NGS FOR CLINICAL DECISION MAKING

EHA Library, James Nolan, 325564

OBINUTUZUMAB SHORT-DURATION INFUSION (SDI) IN PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA: RESULTS FROM THE END OF INDUCTION ANALYSIS OF THE PHASE IV GAZELLE STUDY

EHA Library, Miguel A Canales, 325565

EXAMINATION OF FOLLICULAR LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (FLIPI) SCORE FOR FOLLICULAR LYMPHOMA PATIENTS IN THE RITUXIMAB ERA OUTSIDE CLINICAL TRIALS

EHA Library, Maria K Angelopoulou, 325566

IMMUNONOLOGICAL BIOMARKERS OF FATAL CORONAVIRUS DISEASE 2019 (COVID-19): A STUDY OF 513 PATIENTS INCLUDING HEMATOLOGICAL CASES

EHA Library, Esperanza Martín-Sánchez, 325567

PRESEPSIN AND RESPONSE TO ANTIBIOTIC THERAPY IN FEBRILE NEUTROPENIA OF ONCOHAEMATOLOGICAL PATIENTS

EHA Library, Fabrizio Vianello, 325568

INCREASED USE OF ANTI-INFECTIVE AGENTS AFTER DIAGNOSIS OF MYELODYSPLASTIC SYNDROMES

EHA Library, Johanne Rozema, 325569

IMPACT OF THE CLINICAL MANAGEMENT OF HYPERTENSION, INFLAMMATION AND THROMBOSIS ON THE SURVIVAL OF HOSPITALIZED COVID-19 PATIENTS

EHA Library, Andrea Acebes-Huerta, 325570

HUMAN ERYTHROID PROGENITORS ARE DIRECTLY INFECTED BY SARS-COV-2: IMPLICATIONS FOR EMERGING ERYTHROPOIESIS IN SEVERE COVID19 PATIENTS

EHA Library, Hector HUERGA ENCABO, 325571

HUMORAL IMMUNITY RESPONSES AFTER VACCINATION FOR HEPATITIS B VIRUS IN AUTOGRAFTED PATIENTS: A SINGLE CENTER EXPERIENCE

EHA Library, Naeema Al Musailem, 325572

DETECTION OF SARS-COV-2 INFECTION PREVALENCE IN 474 HEMATOLOGIC PATIENTS UNDER THERAPY WITH A TRIPLE SCREENING PROCEDURE INCLUDING TRIAGE, MOLECULAR NASOPHARYNGEAL SWAB AND RAPID SEROLOGICAL TEST.

EHA Library, Anna Candoni, 325573

COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS – CZECH EXPERIENCE

EHA Library, Jakub Radocha, 325574

EPIDEMIOLOGY AND MORTALITY IN BACTERAEMIA IN ADULT PATIENTS WITH HEMATOLOGIC MALIGNANCIES

EHA Library, BECHIR ACHOUR, 325575

COVID-19 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASES IN BRAZIL: CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS

EHA Library, Karina Tozatto Maio, 325576

CLINICAL OUTCOMES OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES TREATED IN THE COMMUNITY SETTING IN CROATIA

EHA Library, Hrvoje Holik, 325577

INFECTION BY SARS-COV-2 IN HEMATOLOGIC PATIENTS: AN UNICENTRIC RETROSPECTIVE STUDY

EHA Library, Filipa Saraiva, 325578

MEASUREMENT OF VARICELLA ZOSTER IGG ANTIBODY IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yasmine El Chazli, 325579

INVASIVE ASPERGILLOSIS IN HEMATOLOGICAL PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SINGLE-CENTER STUDY

EHA Library, Yuliya Rogacheva, 325580

IMPACT OF ADEQUATE EMPIRICAL BROAD-SPECTRUM ANTIBIOTIC FOR BLOODSTREAM INFECTION IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

EHA Library, Miguel Angel Rodriguez Gil, 325581

IMPACT OF THE ABCB1 DRUG RESISTANCE GENE ON COMPLICATIONS ASSOCIATED WITH COVID-19

EHA Library, Christian Ramos, 325582

A COMPARATIVE OUTCOME ANALYSIS OF COVID-19 VS INFLUENZA INFECTION IN PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Franziska Modemann, 325583

RISK FACTORS AND OUTCOME OF SARS-COV-2 INFECTION IN HEMATOLOGIC PATIENTS – A SINGLE CENTER EXPERIENCE

EHA Library, Marino Narancic, 325584

ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN SUPPORTIVE CARE OF LOW-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Claudio Cerchione, 325585

THE ASSESSMENT OF IMPACT OF COVID-19 IN PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Viola-Maria Popov, 325586

TREATMENT WITH REMDESIVIR, DEXAMETHASONE AND CONVALESCENT PLASMA TRANSFUSION IS SAFE AND BENEFICIAL IN HOSPITALIZED COVID-19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES.

EHA Library, Joanna Barankiewicz, 325587

SLOW INFUSION OF ANTI-THYMOCYTE GLOBULIN SIGNIFICANTLY DECREASED THE INCIDENCE OF REACTIONS AND THE NEED FOR CRITICAL CARE SERVICES

EHA Library, Moussab Damlaj, 325588

ANTIBIOTIC-RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANCY

EHA Library, BECHIR ACHOUR, 325589

ARTERIAL AND VENOUS THROMBOTIC COMPLICATIONS IN HOSPITALIZED PATIENTS WITH COVID-19: EXPERIENCE FROM A MEXICO CITY HEALTH SYSTEM.

EHA Library, Lena Simental-Legarda, 325590

ACUTE LEUKEMIA AND SARS-COV-2 INFECTION: SINGLE CENTRE EXPERIENCE

EHA Library, Nikola Pantic, 325591

THE PROFILE OF FEBRILE NEUTROPENIA IN HEMATOLOGY-ONCOLOGY UNIT; EXPERIENCE OF CHILDREN WELFARE TEACHING HOSPITAL, MEDICAL CITY

EHA Library, Hasanein Ghali, 325592

AUDIT OF CHEMOTHERAPY DISRUPTION DUE TO COVID19 PANDEMIC: PERSPECTIVE FROM A UK DISTRICT GENERAL HOSPITAL

EHA Library, Aldalaq Ahmad, 325593

COMPLICATION, ASSOCIATED WITH CATHETERISATION OF CENTRAL VEIN IN HEMATOLOGY PATIENTS

EHA Library, Nikolay Romanenko, 325594

HEMATOLOGIC CHARACTERISTICS AND C-REACTIVE PROTEIN OF PATIENTS WITH SARS-COV 2 ADMITTED TO A UNIVERSITY HOSPITAL IN BRAZIL.

EHA Library, Marina Dias, 325595

GROWTH OF ANTIBIOTIC RESISTANCE IN THE HEMATOLOGY DEPARTMENT OF CENTRAL KAZAKHSTAN DURING THE COVID-19 PANDEMIC

EHA Library, Ludmila Turgunova, 325596

ALK2 IS A POTENTIAL THERAPEUTIC TARGET IN ANEMIA RESULTING FROM CHRONIC INFLAMMATION

EHA Library, Thomas Backus, 325597

ADMINISTRATION OF ALK2 NEUTRALIZING ANTIBODIES TO CYNOMOLGUS MONKEYS LED TO A SUSTAINED DECREASE IN HEPCIDIN, INCREASE IN CIRCULATING IRON AND INCREASE IN ERYTHROCYTE HEMOGLOBIN

EHA Library, Claire C Tseng, 325598

DISC-B, A SELECTIVE MATRIPTASE-2 INHIBITOR, ELICITED ROBUST INCREASE IN HEPCIDIN-25 AND REDUCTION IN SERUM IRON IN CYNOMOLGUS MONKEYS

EHA Library, Vu Hong, 325599

ALK2 INHIBITION, A NOVEL THERAPEUTIC APPROACH TO IRON OVERLOAD.

EHA Library, Ffolliott Fisher, 325600

ANEMIA AND IRON METABOLISM IN PATIENTS WITH SARS-COV-2 INFECTION: THE ROLE OF INFLAMMATION AND HYPOXIA.

EHA Library, Diletta Maira, 325601

ERYTHROFERRONE, THE MEDIATOR BETWEEN ERYTHROPOISESIS, HEPCIDIN AND IRON METABOLISM, DURING ALLOGENIEC HEMATOPOIETIC STEM CELLS TRANSPLANT.

EHA Library, Michelle Pirotte, 325602

EFFICACY OF IRON SUPPLEMENTS GIVEN ON ALTERNATE DAYS VERSUS CONSECUTIVE DAYS IN THE TREATMENT OF IRON DEFICIENCY ANEMIA IN WOMEN OF REPRODUCTIVE AGE: NON-INFERIORITY, RANDOMIZED CONTROLLED TRIAL

EHA Library, Sasinipa Trithiphen, 325603

NON-CLINICAL SAFETY OF SLN124, A GALNAC CONJUGATED 19-MER DOUBLE-STRANDED SIRNA TARGETING TMPRSS6 FACILITATING EVALUATION IN CLINICAL STUDIES

EHA Library, Simon Chivers, 325604

PRE-TRANSPLANT HYPERFERRITINEMIA CANNOT PREDICT TRANSPLANT OUTCOMES IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANT FOR SEVERE APLASTIC ANEMIA

EHA Library, Fan Lin, 325605

CHANGES IN ERYTHROPOIESIS IN MALARIA-INDUCED ANEMIA

EHA Library, Raffaella Gozzelino, 325606

RELATIONSHIP OF PRE-TRANSPLANT IRON STATUS TO OUTCOMES POST KIDNEY TRANSPLANTATION : A RETROSPECTIVE COHORT

EHA Library, Jan Joel Simpauco, 325607

TMPRSS6 POLYMORPHISMS AND A RISK OF IRON DEFICIENCY ANEMIA IN SCHOOL-AGED CHILDREN

EHA Library, Rawinun Udomponglukkana, 325608

DISSECTION OF MANTLE CELL LYMPHOMA BONE MARROW B LYMPHOCYTES ON THE SINGLE-CELL LEVEL WITH FOCUS ON CLINICAL MARKERS AND SOXC FAMILY MEMBERS

EHA Library, Simone Valentin Hansen, 325609

WHOLE-GENOME CRISPR LIBRARY SCREENS IDENTIFY CD48 AS AN ESSENTIAL MOLECULE IN ADULT T-CELL LEUKEMIA/LYMPHOMA FOR DEFINING SUSCEPTIBILITY TO NATURAL KILLER CELL-MEDIATED CYTOTOXICITY

EHA Library, Masahiro Chiba, 325610

COMPREHENSIVE CHARACTERIZATION OF THE MUTATIONAL LANDSCAPE IN EPSTEIN-BARR VIRUS-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA BY WHOLE-GENOME AND TARGETED AMPLICON-BASED SEQUENCING

EHA Library, Hanno M Witte, 325611

DISEASE AND OUTCOME ASSOCIATED IMMUNE SIGNATURES AT DIAGNOSIS IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Edward Truelove, 325612

ROLE OF PROTEIN KINASES CK1 ALPHA AND CK2 IN CHRONIC ACTIVE BCR-DEPENDENT SIGNALING NETWORK IN MANTLE CELL LYMPHOMA: EFFECTS ON BTK-DIRECTED THERAPY.

EHA Library, Sabrina Manni, 325613

HIGH RISK AGGRESSIVE B-CELL LYMPHOMA ON THE LIQUID BIOPSY

EHA Library, Leo Meriranta, 325614

DDX3X LOSS IS ASSOCIATED WITH AGGRESSIVE PHENOTYPES IN NON-HODGKIN’S LYMPHOMAS

EHA Library, Atish Kizhakeyil, 325615